Host Cofactors and Pharmacologic Ligands Share an Essential Interface in HIV-1 Capsid That Is Lost upon Disassembly
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The HIV-1 capsid is involved in all infectious steps from reverse transcription to integration site selection, and is the target of multiple host cell and pharmacologic ligands. However, structural studies have been limited to capsid monomers (CA), and the mechanistic basis for how these ligands influence infection is not well understood. Here we show that a multi-subunit interface formed exclusively within CA hexamers mediates binding to linear epitopes within cellular cofactors NUP153 and CPSF6, and is competed for by the antiretroviral compounds PF74 and BI-2. Each ligand is anchored via a shared phenylalanine-glycine (FG) motif to a pocket within the N-terminal domain of one monomer, and all but BI-2 also make essential interactions across the N-terminal domain: C-terminal domain (NTD:CTD) interface to a second monomer. Dissociation of hexamer into CA monomers prevents high affinity interaction with CPSF6 and PF74, and abolishes binding to NUP153. The second interface is conformationally dynamic, but binding of NUP153 or CPSF6 peptides is accommodated by only one conformation. NUP153 and CPSF6 have overlapping binding sites, but each makes unique CA interactions that, when mutated selectively, perturb cofactor dependency. These results reveal that multiple ligands share an overlapping interface in HIV-1 capsid that is lost upon viral disassembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 CPSF6 and NUP153 interact with distinct sets of CA residues within the hexamer interface. A molecular surface representation of the CPSF6 and NUP153 binding site in hexameric capsid is shown in gray. The interface is formed between two neighbouring monomers and is shown in a similar orientation to Figure 3. The CPSF6 (A) and NUP153 (B) peptides in the different complexed structures are shown in yellow and pink respectively. The binding ‘footprint’ of each ligand is shown in red for CPSF6 and yellow for NUP153. The footprint was calculated using PISA [44] and is defined as residues containing atoms that become desolvated upon binding (i.e. are within 1.4 Å of the ligand).](https://figures.cochat.ai/paper-figures/327adc62c78b4401a48bf088e2d7894f/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-4.jpg)


![Figure 7 HIV-1 CA hexamer complexes with pharmacologic ligands BI-2 and PF74. Two monomers from hexameric structures complexed with BI-2 (A) and PF74 (B) are shown in a close-up view of the binding site, with one monomer in gray and a second monomer in teal. BI-2 is shown in orange and PF74 in green. Important CA interacting residues are shown as sticks and putative hydrogen bonds indicated by dashed lines. Ligplots [45] are shown for BI-2 (C) and PF74 (D) in which a ball-and-stick representation of the ligand is shown together with CA residues that contribute a hydrogen bond. Other interacting CA residues are indicated with a red-dashed semi-circle. Circled areas indicate interacting CA residues that are shared between both structures. (E) Superposition of the BI-2:hexamer complex (BI-2 in orange) with the previously solved BI-1:CA-NTD complex [28] (BI-1 in blue). The secondary structure of the superposed monomers from each structure is shown in gray, while capsid side-chains from only the hexamer complex are depicted. The adjacent monomer in the hexamer complex is shown in teal. (F) Superposition of the PF74:hexamer complex (PF74 in green) with the previously solved PF74:CA-NTD complex [27] (PF74 in slate). The capsids are colored as in (E).](https://figures.cochat.ai/paper-figures/7cf5249be85940bd90f08d2edaf59d69/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-7.jpg)

![Figure 9 Inhibition of HIV-1 infection by BI-2, PF74 and PF74 derivatives. (A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GFP-encoding HIV-1 vector. For each titration, infectivity is normalised to the level in the absence of inhibitor (100%). (B) Correlation between the IC90 values derived from (A) and the Kd values for purified hexameric capsid as calculated by ITC (Figure 8). The values are highly correlative with a Pearson correlation coefficient of 0.9928 and a P-value of 0.0007. (C) Titration of PF74 or BI-2 onto cells infected with VSV-G pseudotyped GFP-encoding HIV-1 vectors, normalized as in (A). (D) Data from (C) but with infectivity plotted against drug concentration divided by affinity to hexamer as calculated by ITC. (E) Titres of VSV-G pseudotyped GFP-encoding HIV-1 vectors 48 h post-infection and levels of reverse transcription (RT) 4 h post-infection under conditions of PF74 inhibition. For both measures, data are normalized to the values obtained in the absence of inhibitor. (F) Data from (E), except plotted against the calculated level of CA occupancy by PF74. The occupancy was calculated assuming that there are 1500 free sites per capsid and that number of free sites = 1500(1−([PF74]/Kd[PF74])) (G) Infectivity and reverse transcription in cells infected in the presence of PF74 (wash) or when removed after four hours (wash out). Reverse transcription was then measured after a further 4 h, while infectivity was determined 48 h post-infection. (H) Levels of reverse transcription 4 h post-infection of HeLa cells in the presence of PF74 and its derivatives at 20× IC9o drug concentrations.](https://figures.cochat.ai/paper-figures/fc100b1cf62b406592ce6fd8f22ac865/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cleavage and polyadenylation specificity factor 6 (CPSF6), which is a component of the cellular pre-mRNA cleavage and polyadenylation machinery79, binds the same region of capsid as Nup153 (REF.78,80).”
From Structure and function of retroviral integrase (2022) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984 · cited 1×
“The footprint was calculated using PISA [44] and is defined as residues containing atoms that become desolvated upon binding (i.”
MethodLigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
Laskowski, R. A., & Swindells, M. B. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200227u · Cited by 6,471 · cited 1×
“Ligplots [45] are shown for BI-2 (C) and PF74 (D) in which a ball-and-stick representation of the ligand is shown together with CA residues that contribute a hydrogen bond.”
BackgroundIn Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Specific incorporation of cyclophilin A into HIV-1 virions
Franke, E. K., Yuan, H. E. H., & Luban, J. (1994) · Nature · doi:10.1038/372359a0 · Cited by 745
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 2×
“proteins TNPO3, NUP153, NUP358 [4,5,6], and LEDGF [7].”
X-Ray Structures of the Hexameric Building Block of the HIV Capsid
Pornillos, O., Ganser-Pornillos, B. K., Kelly, B. N., Hua, Y., Whitby, F. G., Stout, C. D., Sundquist, W. I., Hill, C. P., & Yeager, M. (2009) · Cell · doi:10.1016/j.cell.2009.04.063 · Cited by 523 · cited 4×
“One potential explanation for this is that all three structures were solved using monomeric CA NTD, whereas a fully assembled HIV-1 capsid is comprised exclusively of multimeric CA, predominately hexamers, containing both NTD-NTD and NTD-CTD interfaces [31].”
BackgroundInfluential
Cited by
Items 101–200 of 290
Truncated CPSF6 Forms Higher-Order Complexes That Bind and Disrupt HIV-1 Capsid
Ning, J., Zhong, Z., Fischer, D. K., Harris, G., Watkins, S. C., Ambrose, Z., & Zhang, P. (2018) · Journal of Virology · doi:10.1128/jvi.00368-18 · Cited by 43
“CPSF6 has been suggested to regulate HIV-1 nuclear entry and integration site targeting through interaction with HIV-1 capsid (12, 13).”
BackgroundAnalysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells
Zila, V., Müller, T. G., Laketa, V., Müller, B., & Kräusslich, H.-G. (2019) · mBio · doi:10.1128/mbio.02501-19 · Cited by 41
Strain and rupture of HIV-1 capsids during uncoating
Yu, A., Lee, E. M. Y., Briggs, J. A. G., Ganser-Pornillos, B. K., Pornillos, O., & Voth, G. A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117781119 · Cited by 40
“The NTD–CTD interface is the binding site for phenylalanine glycine motifs required for nuclear import of the capsid (21) and small-molecule inhibitors including PF74 (22) and Lenacapavir (23) that disrupt HIV function.”
BackgroundHIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules
Saito, A., & Yamashita, M. (2021) · Retrovirology · doi:10.1186/s12977-021-00577-x · Cited by 44
“The N57 residue in the helix 3 is a key amino acid residue involved in capsid binding to CPSF6 and other host factors [95, 187, 188], and its mutations change several phenotypic characteristics differently from both N74D and A77V mutations.”
BackgroundInfluentialConformational plasticity of a native retroviral capsid revealed by x-ray crystallography
Obal, G., Trajtenberg, F., Carrión, F., Tomé, L., Larrieux, N., Zhang, X., Pritsch, O., & Buschiazzo, A. (2015) · Science · doi:10.1126/science.aaa5182 · Cited by 39
Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.
Xu, J. P., Francis, A. C., Meuser, M. E., Mankowski, M. K., Ptak, R. G., Rashad, A. A., Melikyan, G. B., & Cocklin, S. (2018) · PubMed · Cited by 39
Schifferdecker, S., Žíla, V., Müller, T. G., Sakin, V., Anders‐Össwein, M., Laketa, V., Kräusslich, H., & Müller, B. (2022) · mBio · doi:10.1128/mbio.01959-22 · Cited by 44
“(60, 62), consistent with functional replacement of A14 by a nonnatural CpK residue in the current study.”
BackgroundCapsid–host interactions for HIV-1 ingress
Jang, S., & Engelman, A. (2023) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00048-22 · Cited by 42
Elasticity of the HIV-1 core facilitates nuclear entry and infection
Deshpande, A., Bryer, A. J., Andino-Moncada, J. R., Shi, J., Hong, J., Torres, C. M., Harel, S., Francis, A. C., Perilla, J. R., Aiken, C., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012537 · Cited by 44
“HIV-1 core elasticity and infection [17,21,51], suggesting that the inhibitors act by steric inhibition of the capsid binding to the nucleopore.”
BackgroundSelf-citationModular HIV-1 Capsid Assemblies Reveal Diverse Host-Capsid Recognition Mechanisms
Summers, B. J., Digianantonio, K. M., Smaga, S., Huang, P.-T., Zhou, K., Gerber, E. E., Wang, W., & Xiong, Y. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.07.007 · Cited by 39
“specifically target unique high-order interfaces only found in the assembled CA lattice (Bhattacharya et al., 2014; Biris et al., 2012; Fribourgh et al., 2014; Li et al., 2016; Liu et al., 2016; Morger et al., 2018; Price et al., 2014; Yang et al., 2012).”
BackgroundJennings, J., Shi, J., Varadarajan, J., Jamieson, P. J., & Aiken, C. (2020) · mBio · doi:10.1128/mbio.02820-20 · Cited by 48
“PF74 binds to a site in the CA hexamer that is distinct from that bound by IP6 (25, 26).”
BackgroundSelf-citationThe HIV-1 capsid core is an opportunistic nuclear import receptor
Xue, G., Yu, H. J., Buffone, C., Huang, S., Lee, K., Goh, S. L., Gres, A. T., Guney, M. H., Sarafianos, S. G., Luban, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39146-5 · Cited by 44
Hou, Z., Shen, Y., Fronik, S., Shen, J., Shi, J., Xu, J., Chen, L., Hardenbrook, N. J., Thompson, C., Neumann, S., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02054-z · Cited by 40
Self-citationMcCarthy, K. R., Kirmaier, A., Autissier, P., & Johnson, W. E. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005085 · Cited by 38
“and Nup-153 (Fig 4 and S9 Fig) [86–89].”
BackgroundLive-Cell Imaging of Early Steps of Single HIV-1 Infection
Francis, A. C., & Melikyan, G. B. (2018) · Viruses · doi:10.3390/v10050275 · Cited by 33
“PF-3450074 (PF-74) binds a pocket formed by an interface between the CA N-terminal and C-terminal domains [73], which overlaps with the binding sites of the cellular proteins, NUP153 and CPSF6, involved in the nuclear import of HIV-1 [74,75].”
BackgroundHow HIV-1 Gag Manipulates Its Host Cell Proteins: A Focus on Interactors of the Nucleocapsid Domain
Klingler, J., Anton, H., Réal, É., Zeiger, M., Moog, C., Mély, Y., & Boutant, E. (2020) · Viruses · doi:10.3390/v12080888 · Cited by 44
“Another nucleoporin, Nup153, a component of the nuclear basket of the NPC, interacts with hexameric CA with much higher affinity than with CA monomers [103,104] and facilitates nuclear entry.”
BackgroundHIV-1 Capsid Core: A Bullet to the Heart of the Target Cell
Toccafondi, E., Lener, D., & Negroni, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.652486 · Cited by 33
Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules
Vernekar, S. K. V., Sahani, R. L., Casey, M. C., Kankanala, J., Wang, L., Kirby, K. A., Du, H., Zhang, H., Tedbury, P. R., Xie, J., et al. (2020) · Viruses · doi:10.3390/v12040452 · Cited by 35
“In addition to accommodating the binding [25,29,30] of PF74 and BI-2, a smaller CA-targeting molecule (Figure 1B), the same pocket is also used by important cellular factors, including [29,30]: Nup153, a nucleoporin important for nuclear transport of viral preintegration complexes (PICs); and CPSF6 which transports HI…”
BackgroundThe Role of Capsid in HIV-1 Nuclear Entry
Guedán, A., Caroe, E. R., Barr, G. C. R., & Bishop, K. N. (2021) · Viruses · doi:10.3390/v13081425 · Cited by 33
“Later, it was shown that HIV-1 CA could bind the phenylalanine-glycine (FG) repeats found in multiple Nups [97] but two Nups have been particularly well characterised with regard to HIV-1 interactions: Nup358 [72,81,110] and Nup153 [46,47,96,111].”
BackgroundInfluentialHIV-1 capsid and viral DNA integration
Dwivedi, R., Prakash, P., Kumbhar, B. V., Balasubramaniam, M., & Dash, C. (2023) · mBio · doi:10.1128/mbio.00212-22 · Cited by 34
Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?
Sumner, R. P., Thorne, L., Fink, D., Khan, H., Milne, R. S. B., & Towers, G. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01246 · Cited by 28
“This hypothesis is supported by structural studies that revealed that pairs of cytoplasmic and nuclear cofactors, for example, CypA/Nup358 and CPFS6/Nup153, have overlapping binding sites on the surface of the capsid (39), suggesting that an exchange of cofactor binding may happen at the nuclear pore to control uncoat…”
MethodFluorine in anti-HIV drugs approved by FDA from 1981 to 2023
Han, S., & Lu, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115586 · Cited by 30
HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors
Spearman, P. W. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150902102143 · Cited by 37
“Structural studies of cellular factors bound to the capsid are increasingly revealing binding pockets that can be similarly targeted by drugs [66], some of which will be described later in this review.”
BackgroundRecent advances in HIV-1 Gag inhibitor design and development
Dick, A., & Cocklin, S. (2020) · Molecules · doi:10.3390/molecules25071687 · Cited by 28
Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation
Zhyvoloup, A., Melamed, A., Anderson, I., Planas, D., Lee, C.-H., Kriston-Vizi, J., Ketteler, R., Merritt, A. T., Routy, J., Ancuța, P., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006460 · Cited by 28
“Certain CA point mutations, such as N74D, are independent of Nup358, Nup153, CPSF6 and TNPO3 for infection, and show a different integration site selection compared to wild type virus [7,23,25].”
BackgroundLenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice
Li, C., Burdick, R. C., Siddiqui, R., Janaka, S. K., Hsia, R., Hu, W.-S., & Pathak, V. K. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420497122 · Cited by 33
“Both PF74 and LEN can inhibit multiple steps in the early stage of infection, including reverse transcription, nuclear import, and integration, likely by directly altering capsid stability ( 17 , 23 , 27 ) and interfering with host factor binding ( 23 , 28 , 29 ).”
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle
Nunzio, F. D., Uversky, V. N., & Mouland, A. J. (2023) · Retrovirology · doi:10.1186/s12977-023-00619-6 · Cited by 31
Chemical profiling of HIV-1 capsid-targeting antiviral PF74
Wang, L., Casey, M. C., Vernekar, S. K. V., Ha, T., Sahani, R. L., Kirby, K. A., Du, H., Hachiya, A., Zhang, H., Tedbury, P. R., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112427 · Cited by 30
Jang, S., Bedwell, G. J., SINGH, S. P., Yu, H. J., Arnarson, B., Singh, P. K., Radhakrishnan, R., Douglas, A. W., Ingram, Z., Freniere, C., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae769 · Cited by 30
“Thus, the PrLD-derived FG peptide 276-PVLFPGQPFGQPPLG bound CA hexamers ∼ 10-fold more effectively than it bound the isolated CA N-terminal domain ( 31 , 95 , 96 ).”
BackgroundSchaller, T., Bulli, L., Pollpeter, D., Betancor, G., Kutzner, J., Apolonia, L., Herold, N., Burk, R., & Malim, M. H. (2017) · Journal of Virology · doi:10.1128/jvi.00463-17 · Cited by 27
IP6‐stabilised HIV capsids evade cGAS/STING‐mediated host immune sensing
Papa, G., Albecka, A., Mallery, D. L., Vaysburd, M., Renner, N., & James, L. C. (2023) · EMBO Reports · doi:10.15252/embr.202256275 · Cited by 28
“For instance, the binding site for CPSF6 and Nup153, both factors that only engage once HIV-1 reaches the nucleus, is located at the interface between monomers in capsid assemblies (Price et al , 2014).”
Self-citationOligomeric viral proteins: small in size, large in presence
Jayaraman, B., Smith, A. M., Fernandes, J. D., & Frankel, A. D. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1215406 · Cited by 27
“They specifically recognize the assembled hexamer in the mature CA, binding at the NTD–CTD interface (Bhattacharya et al., 2014; Price et al., 2014), illustrating the functional role of a specific oligomeric structure.”
BackgroundIdentification of a small molecule HIV-1 inhibitor that targets the capsid hexamer
Xu, J. P., Branson, J. D., Lawrence, R., & Cocklin, S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.087 · Cited by 25
Eschbach, J. E., Elliott, J. L., Li, W., Zadrozny, K. K., Davis, K., Mohammed, S. J., Lawson, D. Q., Pornillos, O., Engelman, A., & Kutluay, S. B. (2020) · Journal of Virology · doi:10.1128/jvi.00984-20 · Cited by 22
Wang, W., Zhou, J., Halambage, U. D., Jurado, K. A., Jamin, A. V., Wang, Y., Engelman, A., & Aiken, C. (2017) · Journal of Virology · doi:10.1128/jvi.02155-16 · Cited by 22
“PF74 can destabilize the viral capsid, but its major antiviral effect occurs between reverse transcription and integration (19, 27, 49).”
BackgroundSelf-citationCharacterization of HIV-1 uncoating in human microglial cell lines
Ingram, Z., TAYLOR, M., Okland, G., Martin, R., & Hulme, A. E. (2020) · Virology Journal · doi:10.1186/s12985-020-01301-5 · Cited by 25
Impact of Chromatin on HIV Replication
Agosto, L. M., Gagné, M., & Henderson, A. J. (2015) · Genes · doi:10.3390/genes6040957 · Cited by 24
The Viral Capsid: A Master Key to Access the Host Nucleus
Blanco-Rodriguez, G., & Nunzio, F. D. (2021) · Viruses · doi:10.3390/v13061178 · Cited by 24
“drophobic pockets formed between hexamers [130,131].”
BackgroundHIV Capsid Inhibitors Beyond PF74
McArthur, C. P., Gallazzi, F., Quinn, T. P., & Singh, K. (2019) · Diseases · doi:10.3390/diseases7040056 · Cited by 24
“A superposition of capsid bound to PF74 (PDB files 4XFZ and 5HGL) [9,69] and BI-2 (PDB file 4U0F) [57] demonstrates that two phenyl rings of BI-2 superposed well with the phenyl rings of PF74 (Figure 2b) [65].”
BackgroundInfluentialThe Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter
AlBurtamani, N., Paul, A., & Fassati, A. (2021) · Viruses · doi:10.3390/v13061161 · Cited by 23
“CPSF6 is a nuclear protein that functions in processing mRNA for polyadenylation as a component of the mammalian cleavage factor 1 (CFIm).”
BackgroundInfluentialGres, A. T., Kirby, K. A., McFadden, W. M., Du, H., Liu, D., Xu, C., Bryer, A. J., Perilla, J. R., Shi, J., Aiken, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41197-7 · Cited by 21
Self-citationMeuser, M. E., Reddy, P. A. N., Dick, A., Maurancy, J. M., Salvino, J. M., & Cocklin, S. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01810 · Cited by 22
The Human Immunodeficiency Virus Capsid Is More Than Just a Genome Package
James, L. C., & Jacques, D. A. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-092917-043430 · Cited by 18
Self-citationFluorescence Biosensor for Real-Time Interaction Dynamics of Host Proteins with HIV-1 Capsid Tubes
Lau, D., Walsh, J. C., Peng, W., Shah, V. B., Turville, S. G., Jacques, D. A., & Böcking, T. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b08521 · Cited by 20
Self-citationMultiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid
Sultana, T., Mamede, J. I., Saito, A., Ode, H., Nohata, K., Cohen, R., Nakayama, E. E., Iwatani, Y., Yamashita, M., Hope, T. J., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00986-19 · Cited by 18
Lingappa, J. R., Lingappa, V. R., & Reed, J. C. (2021) · Viruses · doi:10.3390/v13030451 · Cited by 23
“PF74 binds a conserved pocket in CA-NTD at the interface with CA-CTD that also serves as the binding site for the host factors cleavage and polyadenylation specific factor 6 (CPSF6) and nucleoporin 153 (NUP153); thus, PF74 may act as a competitive inhibitor of CPSF6 and NUP153 binding to CA [62,66,67].”
BackgroundSahani, R. L., Diana‐Rivero, R., Vernekar, S. K. V., Wang, L., Du, H., Zhang, H., Castaner, A. E., Casey, M. C., Kirby, K. A., Tedbury, P. R., et al. (2021) · Viruses · doi:10.3390/v13030479 · Cited by 20
“Furthermore, the PF74 binding site also accommodates CPSF6 and NUP153, the host factors required for nuclear entry and integration site targeting of viral PICs (Figure 1D) [18].”
BackgroundInfluentialCanales, E., Tse, W. C., Schroeder, S. D., Chou, C., Liu, Q., Zhang, J., Lazerwith, S. E., Morganelli, P., Saito, R. D., Brizgys, G., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01625 · Cited by 24
Zhang, X., Sun, L., Meuser, M. E., Zalloum, W. A., Xu, S., Huang, T., Cherukupalli, S., Jiang, X., Ding, X., Tao, Y., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113848 · Cited by 20
Dostálková, A., Kaufman, F., Křížová, I., Vokatá, B., Ruml, T., & Rumlová, M. (2020) · Journal of Virology · doi:10.1128/jvi.00991-20 · Cited by 22
“HIV-1 core stability is affected by the presence of various host cell factors that are recruited and bind inside the pocket formed by the CA-NTD and CA-CTD interface (25, 26).”
BackgroundThe HIV-1 Capsid: From Structural Component to Key Factor for Host Nuclear Invasion
Scoca, V., & Nunzio, F. D. (2021) · Viruses · doi:10.3390/v13020273 · Cited by 28
Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors
Wilbourne, M., & Zhang, P. (2021) · Viruses · doi:10.3390/v13020246 · Cited by 24
“Inhibitors include those targeted at the CA-SP1 junction in the immature particle (termed maturation inhibitors), but also small molecules which bind the NTD-CTD interface within the capsomere of the mature viral particle [9,98,99].”
BackgroundInfluentialHIV-1 CA Inhibitors Are Antagonized by Inositol Phosphate Stabilization of the Viral Capsid in Cells
Sowd, G. A., Shi, J., & Aiken, C. (2021) · Journal of Virology · doi:10.1128/jvi.01445-21 · Cited by 20
“However, in cells, depletion of IP6 and the related metabolite inositol (1, 3, 4, 5, 6) pentakisphosphate (IP5) via knockout (KO) of the genes encoding inositol polyphosphate multikinase (IPMK) or inositol-pentakisphosphate 2-kinase (IPPK), the cellular kinases required for IP5 and/or IP6 biogenesis, has a relatively…”
BackgroundSelf-citationTravis, C., Nakamura, T., Amano, M., Takamune, N., Matsuoka, M., & Nakata, H. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01039-21 · Cited by 18
“Representative anti-CA compounds, such as CAP-1 (13, 14), PF-3450074 (PF74) (15, 16), ebselen (17), BD-1, BM-1 (18), I-XW-053 (19), and C1 (20) have been discovered, although none have been approved for clinical use by the FDA.”
Xu, S., Sun, L., Zalloum, W. A., Zhang, X., Huang, T., Ding, D., Tao, Y., Zhao, F., Gao, S., Kang, D., et al. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.06.034 · Cited by 18
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development
McGraw, A., Hillmer, G., Mehedincu, S. M., Hikichi, Y., Gagliardi, S., Narayan, K., Tibebe, H., Marquez, D., Bose, L. M., Keating, A., et al. (2024) · Viruses · doi:10.3390/v16091423 · Cited by 20
“In response to viral infections, CPSF6 binds to the HIV-1 CA hexamer of the core to facilitate its nuclear import, which is crucial for infection (Figures 1D and 3) [46,47].”
BackgroundInfluentialControl of yeast retrotransposons mediated through nucleoporin evolution
Rowley, P. A., Patterson, K., Sandmeyer, S. B., & Sawyer, S. L. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007325 · Cited by 17
Gruenke, P. R., Aneja, R., Welbourn, S., Ukah, O. B., Sarafianos, S. G., Burke, D. H., & Lange, M. J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1293 · Cited by 16
“We also evaluated competition between aptamer CA152 and PF74, a small molecule that inhibits HIV-1 replication (71,74,81) and that binds CA in a pocket located at the CANTD–CACTD interface of assembled hexamers with a Kd of 176 ± 78 nM (71).”
Sowd, G. A., Shi, J., Fulmer, A. N., & Aiken, C. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011423 · Cited by 18
Self-citationEmerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus
Padron, A., Prakash, P., Pandhare, J., Luban, J., Aiken, C., Balasubramaniam, M., & Dash, C. (2023) · Journal of Virology · doi:10.1128/jvi.00732-23 · Cited by 20
Self-citationCraveur, P., Gres, A. T., Kirby, K. A., Liu, D., Hammond, J. A., Deng, Y., Forli, S., Goodsell, D. S., Williamson, J. R., Sarafianos, S. G., et al. (2019) · mBio · doi:10.1128/mbio.02858-18 · Cited by 17
Multifunctionality of F-rich nucleoporins
Heinß, N., Sushkin, M. E., Yu, M., & Lemke, E. A. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200357 · Cited by 15
SARS-CoV-2 infects brain choroid plexus and disrupts the blood-CSF-barrierPreprint
Pellegrini, L., Albecka, A., Mallery, D. L., Kellner, M. J., Paul, D., Carter, A. P., James, L. C., & Lancaster, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.20.259937 · Cited by 15
“Preparation of viruses Replication deficient VSV-G or SARS Cov2 pseudotyped HIV-1 virions were produced in HEK293T cells by transfection with pMDG2 or pCAGGS-Spike △c19, pCRV GagPol and CSGW as described previously (Price et al., 2014).”
MethodSelf-citationDirect visualization of HIV-1 core nuclear import and its interplay with the nuclear pore
Hou, Z., Fronik, S., Shen, Y., Chen, L., Thompson, C., Neumann, S., & Zhang, P. (2025) · EMBO Reports · doi:10.1038/s44319-025-00567-6 · Cited by 16
“…such as CPSF6 which has been implicated to direct the capsid to the site of integration after traversing through the NPC (Bejarano et al, 2019; Bhattacharya et al, 2014; Burdick et al, 2020; Matreyek et al, 2013; Ning et al, 2018; Price et al, 2014; Selyutina et al, 2020; Zhong et al, 2021).”
The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription
Jennings, J., Bracey, H., Hong, J., Nguyen, D. T., Dasgupta, R., Rivera, A. V., Sluis‐Cremer, N., Shi, J., & Aiken, C. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011810 · Cited by 14
Self-citationKleinpeter, A. B., Mallery, D. L., Renner, N., Albecka, A., Klarhof, J. O., Freed, E. O., & James, L. C. (2024) · Nature Communications · doi:10.1038/s41467-024-51971-w · Cited by 15
Self-citationDarlix, J., de ROCQUIGNY, H., & Mély, Y. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160101-t · Cited by 17
Self-Assembly of Fluorescent HIV Capsid Spheres for Detection of Capsid Binders
Lau, D., Walsh, J. C., Mousapasandi, A., Ariotti, N., Shah, V. B., Turville, S. G., Jacques, D. A., & Böcking, T. (2020) · Langmuir · doi:10.1021/acs.langmuir.0c00103 · Cited by 14
Self-citationMolecular frustration: a hypothesis for regulation of viral infections
Twarock, R., Towers, G. J., & Stockley, P. G. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.07.003 · Cited by 15
Zhang, X., Sun, L., Xu, S., Shao, X., Li, Z., Ding, D., Jiang, X., Zhao, S., Cocklin, S., Clercq, E. D., et al. (2022) · Molecules · doi:10.3390/molecules27217640 · Cited by 14
Comparison of Biochemical Properties of HIV-1 and HIV-2 Capsid Proteins
Miyazaki, Y., Miyake, A., Doi, N., Koma, T., Uchiyama, T., Adachi, A., & Nomaguchi, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01082 · Cited by 15
“…2003; Zhang et al., 2008; Tian et al., 2009; Blair et al., 2010; Jin et al., 2010; Curreli et al., 2011; Shi et al., 2011; Kortagere et al., 2012; Lemke et al., 2012; Lamorte et al., 2013; Matreyek et al., 2013; Bhattacharya et al., 2014; Fricke et al., 2014; Peng et al., 2014; Price et al., 2014).”
BackgroundUnravelling viral dynamics through molecular dynamics simulations - A brief overview
Borkotoky, S., Dey, D., Hazarika, Z., Joshi, A., & Tripathi, K. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106908 · Cited by 12
Antiviral Properties of HIV-1 Capsid Inhibitor GSK878
Wang, C., Huang, H., Mallon, K., Valera, L., Parcella, K. E., Cockett, M. I., Kadow, J. F., Gillis, E. P., Krystal, M., & Fridell, R. A. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01694-22 · Cited by 13
“CPSF6, Nup153, and Sec24C) (49, 75, 76) and/or by altering CA core stability.”
BackgroundA simple, high-throughput stabilization assay to test HIV-1 uncoating inhibitors
Dostálková, A., Hadravová, R., Kaufman, F., Křížová, I., Škach, K., Flegel, M., Hrabal, R., Ruml, T., & Rumlová, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-53483-w · Cited by 12
HIV-1 mutants that escape the cytotoxic T-lymphocytes are defective in viral DNA integration
Balasubramaniam, M., Davids, B.-O., Bryer, A., Xu, C., Thapa, S., Shi, J., Aiken, C., Pandhare, J., Perilla, J. R., & Dash, C. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac064 · Cited by 11
“The HIV-1 capsid structure possesses critical binding interfaces for host factor recognitions (32, 52).”
BackgroundSelf-citationSarkar, S., Balakrishnan, K., Chintala, K., Mohareer, K., Luedde, T., Vasudevan, A. A. J., Münk, C., & Banerjee, S. (2022) · Viruses · doi:10.3390/v14112503 · Cited by 15
“Though several host factors associated with PIC have been identified, their functional role in HIV-1 integration remains elusive [84].”
BackgroundInfluentialPF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles
Dostálková, A., Škach, K., Kaufman, F., Křížová, I., Hadravová, R., Flegel, M., Ruml, T., Hrabal, R., & Rumlová, M. (2020) · Molecules · doi:10.3390/molecules25081895 · Cited by 15
“PF74 binds by its phenylalanine core to the pocket within the CA-NTD formed by the helices H3, H4, H5, and H7, while the indole ring interacts with the CA-CTD of the adjacent subunit [22,47,51,54].”
BackgroundDesign and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein
Akther, T., McFadden, W. M., Zhang, H., Kirby, K. A., Sarafianos, S. G., & Wang, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073734 · Cited by 12
“Notably, the two most prominent CA inhibitor types, represented by PF74 [11,13–15] ( 1 ) and GS-6207 [16,17] ( 2 ), both bind to this pocket to compete against NUP153, CPSF6 [10,11,18], and Sec24C [2,12] in addition to impacting the capsid stability.”
BackgroundGuedán, A., Burley, M., Caroe, E. R., & Bishop, K. N. (2024) · Viruses · doi:10.3390/v16050670 · Cited by 10
“It binds to CA by virtue of a Phe-Gly (FG) peptide that engages the FG-binding pocket formed between the N-terminal domain (NTD) of one CA monomer and the C-terminal domain (CTD) of the adjacent CA monomer in the CA hexamer [44,45].”
BackgroundArg18 Substitutions Reveal the Capacity of the HIV-1 Capsid Protein for Non-Fullerene Assembly
Schirra, R. T., dos Santos, N. F. B., Ganser‐Pornillos, B. K., & Pornillos, O. (2024) · Viruses · doi:10.3390/v16071038 · Cited by 10
“2D class averages revealed pentamers connected to each other (black arrows in Figure 5A), which, in classical quasi-equivalent icosahedral systems, is only allowed in T = 1 capsids.”
BackgroundImpact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavir
Hansen, D., Hendricks, M. R., Chang, S., Cai, A., Perry, J. K., Aeschbacher, T., Martin, R., Cihlář, T., & Yant, S. R. (2025) · mBio · doi:10.1128/mbio.00187-25 · Cited by 14
Ingram, Z., Fischer, D. K., & Ambrose, Z. (2021) · Viruses · doi:10.3390/v13112237 · Cited by 12
“CPSF6 binds to the HIV-1 capsid through multiple interactions with a hydrophobic pocket formed by helices 3, 4, and 5, in which alteration of key residues, such as N74, abolish binding [24,69,70].”
BackgroundHIV-1 binds dynein directly to hijack microtubule transport machinery
Badieyan, S., Lichon, D., Keceli, S. K., Andreas, M. P., Gillies, J. P., Peng, W., Shi, J., DeSantis, M. E., Aiken, C., Böcking, T., et al. (2025) · Science Advances · doi:10.1126/sciadv.adn6796 · Cited by 11
Self-citationZhang, D., Luo, R., Xu, L., Yang, L., Xu, X., Bedwell, G. J., Engelman, A., Zheng, Y., & Chang, S. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.104544 · Cited by 10
Lad, L., Clancy, S., Koditek, D., Wong, M. H. L., Jin, D., Niedziela‐Majka, A., Papalia, G. A., Hung, M., Yant, S. R., Somoza, J. R., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00151 · Cited by 10
He, H., Xue, J., Wang, W., Liu, L., Ye, C., Cong, Z., Kimata, J. T., Qin, C., & Zhou, P. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.135 · Cited by 10
“Prematurely uncoated incoming HIV-1 core triggers cytosolic sensors and nucleases, 58 assembled capsid proteins are required for properly engaging the nuclear pore complex, 59 and intact capsids have been observed at the nuclear envelope.”
Cyclophilin A facilitates HIV-1 integration
Padron, A., Dwivedi, R., Chakraborty, R., Prakash, P., Kim, K., Shi, J., Ahn, J., Pandhare, J., Luban, J., Aiken, C., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00947-24 · Cited by 10
“PF74 binds to a pocket at the NTD–CTD inter-subunit interface of CA and exhibits a concentration-dependent anti-viral activity (33, 101–104).”
Self-citationRole of Transportin-SR2 in HIV-1 Nuclear Import
Tabasi, M., Nombela, I., Janssens, J., Lahousse, A. P., Christ, F., & Debyser, Z. (2021) · Viruses · doi:10.3390/v13050829 · Cited by 11
“found that CPSF6 and NUP153 have an overlapping binding site, which is actually part of a larger protein–protein interface that only exists in a hexameric CA [86].”
BackgroundDesign, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors
Li, J., Jiang, X., Dick, A., Sharma, P. P., Chen, C., Rathi, B., Kang, D., Wang, Z., Ji, X., Lee, K., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116414 · Cited by 9
Looking for Novel Capsid Protein Multimerization Inhibitors of Feline Immunodeficiency Virus
Sierra, N., Folio, C., Robert, X., Long, M., Guillon, C., & Álvarez, G. (2018) · Pharmaceuticals · doi:10.3390/ph11030067 · Cited by 10
The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infection
Rohlfes, N., Radhakrishnan, R., Singh, P. K., Bedwell, G. J., Engelman, A., Dharan, A., & Campbell, E. M. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012354 · Cited by 9
Lenacapavir allosterically remodels the HIV-1 capsid
dos Santos, N. F. B., Lewis, J. A., Hansen, M., Pereira, M. J. B., Christensen, D. E., Sundquist, W. I., Ganser‐Pornillos, B. K., & Pornillos, O. (2026) · Science Advances · doi:10.1126/sciadv.aed8384 · Cited by 8
The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration
Marquis, K. A., Everett, J. K., Cantu, A., McFarland, A. G., Sherrill-Mix, S. A., Krystal, M., Parcella, K. E., Gillis, E. P., Fridell, R. A., & Bushman, F. D. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0161 · Cited by 8
“4,14,20 The capsid is known to bind cellular proteins, including CPSF6, Nup98, Nup153, Nup358, and Cyclophilin A. 3–5,10– 13 , 20, 23–”
Kizito, F., Nguyen, K., Mbonye, U. R., Shukla, M., Luttge, B. G., Checkley, M. A., Agaponova, A. V., Leskov, K., & Karn, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202003121 · Cited by 9
May I Help You with Your Coat? HIV-1 Capsid Uncoating and Reverse Transcription
Arribas, L., Menéndez‐Arias, L., & Betancor, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137167 · Cited by 11
“A monomeric CA (PDB fi le 4XFY, [90]) has been highlighted in cyan in the pentamer and is depicted next to it.”
BackgroundThe Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
Schaller, T., & Herold, N. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094914 · Cited by 8
CPSF6 promotes HIV-1 preintegration complex function
Chaudhuri, E., Jang, S., Chakraborty, R., Radhakrishnan, R., Arnarson, B., Prakash, P., Cornish, D., Rohlfes, N., Singh, P. K., Shi, J., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00490-25 · Cited by 8
Self-citationCook, M., Freniere, C., Wu, C., Lozano, F., & Xiong, Y. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115245 · Cited by 7
Uncovering the release mechanism of nucleotide import by HIV-1 capsid
Song, G. (2020) · Physical Biology · doi:10.1088/1478-3975/abbf32 · Cited by 8
“It has been long recognized as a potential drug target [9, 10].”
BackgroundDick, A., Meuser, M. E., & Cocklin, S. (2022) · Biomolecules · doi:10.3390/biom12050695 · Cited by 7
“In particular, an interprotomer pocket within the hexamer is a binding site for key host dependency factors [10,24,25] and is the target of compounds GS-CA1 [51] and PF-3450074 (PF-74) [10,24,25,52–54].”
Background
Metadata
- Authors
- Price, A. J., Jacques, D. A., McEwan, W. A., Fletcher, A. J., Essig, S., Chin, J. W., Halambage, U. D., Aiken, C., & James, L. C.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Vanderbilt University (US)
- Corresponding author
- James, Leo C.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-30
- Volume
- 10
- Issue
- 10
- Pages
- e1004459
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4214760
- OpenAlex
- W2170915201
- Cited by
- 284
- References
- 45
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 23 · 2023: 24 · 2022: 21 · 2021: 41 · 2020: 31 · 2019: 28 · 2018: 24 · 2017: 8 · 2016: 19 · 2015: 20 · 2014: 2
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- UTS ePRESS (University of Technology Sydney) (submittedVersion)
- Funders
- National Institutes of Health
- Medical Research Council (U105181010)
- National Health and Medical Research Council (1036521)
- National Institute of Allergy and Infectious Diseases (R01AI089401)
- FP7 Ideas: European Research Council (281627)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 capsid, host cofactors, Nup153, CPSF6, capsid disassembly, conformational dynamics, antiretroviral drugs
- MeSH terms
- Binding Sites, Capsid, Humans, Indoles, Ligands, Models, Molecular, Models, Structural, Mutation, Phenylalanine, Polycyclic Compounds, Protein Binding, Virion, HIV-1, HIV Infections, Protein Structure, Tertiary, Anti-HIV Agents, Nuclear Pore Complex Proteins, Capsid Proteins, mRNA Cleavage and Polyadenylation Factors, Reverse Transcription, Polymerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.